Drawing for DELAVIE HEALTH

USPTO serial 97266726

DELAVIE HEALTH

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BLAKESLEE, RICHARD A
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DELAVIE HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brandon P. Leahy

Brandon P. Leahy WILSON SONSINI GOODRICH & ROSATI650 PAGE MILL ROADPALO ALTO, CA 94304-1050United States

Goods and services

ClassDescriptionStatusFirst use
001microbes and microbially derived products being enzymes for use in the manufacture of cosmetics and medicated productsACTIVE—
003cosmetics, sunscreens being sunscreen preparations, face serums being non-medicated skin serums, non-medicated skin care lotions, beauty creams, body creams, exfoliant creams, hand creamsACTIVE—
005medicated ointments for treating dermatological conditions, sunburn, rash, or promoting hair growth, medicated sunscreens, medicated serums for treatment of skin, hair, face, scalp, or body, medicated lotions for skin, hair, face, scalp, or body, medicated creams for skin, hair, face, scalp, or bodyACTIVE—
042scientific and medical research and development; product research and developmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 13, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 13, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 17, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 17, 2026EX5GSOU EXTENSION 5 GRANTED—
Jan 16, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 29, 2025EXT5SOU EXTENSION 5 FILED—
Aug 29, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 5, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 4, 2025EX4GSOU EXTENSION 4 GRANTED—
Mar 4, 2025EXT4SOU EXTENSION 4 FILED—
Mar 4, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 7, 2025DOCKASSIGNED TO EXAMINER—
Sep 6, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 6, 2024EX3GSOU EXTENSION 3 GRANTED—
Sep 6, 2024EXT3SOU EXTENSION 3 FILED—
Sep 6, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 1, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 29, 2024EX2GSOU EXTENSION 2 GRANTED—
Feb 29, 2024EXT2SOU EXTENSION 2 FILED—
Feb 29, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 5, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 1, 2023EX1GSOU EXTENSION 1 GRANTED—
Sep 1, 2023EXT1SOU EXTENSION 1 FILED—
Sep 1, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 7, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 10, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 10, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 21, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 2, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 2, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Dec 2, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 2, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 2, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 29, 2022DOCKASSIGNED TO EXAMINER—
Feb 18, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 17, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance